Peter Libby: Inflammation and Traditional Risk Factors Work Together in Cardiovascular Disease
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, reposted from International Atherosclerosis Society on LinkedIn:
”Informative new vignettes about Inflammation and Cardiovascular Disease. Inflammation and traditional risk factors work together!
The title echoes a paper I did a few years ago: Strandberg TE, Libby P, Kovanen PT. A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy? Cardiovasc Pharmacol 2021;7(3):238-241. ”
Qutoing International Atherosclerosis Society‘s post:
”It’s Inflammation Monday!
Every Monday, IAS will be highlighting the recordings of the live lectures from the Inflammation Academy, held in Madrid on August 28, 2025.
For the first lecture highlight, hear from Peter Libby, MD, as he speaks on how inflammatory mechanisms link traditional risk factors to adverse cardiovascular events.
Watch to learn more.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 23:31Rana Al-Hrout: MAHA – More Than Schistocytes
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection